Korean J Pediatr Search

CLOSE


Instructions for authors

  • HOME
  • AUTHOR INFORMATION
  • Instructions for authors

Revised on January, 2019

Korean Journal of Pediatrics (Korean J Pediatr) is an international, peer-reviewed monthly journal of medicine published in English. It is the official publication of The Korean Pediatric Society. Korean J Pediatr covers clinical and experimental research works relevant to all aspects of child healthcare and related articles in pediatrics: education, training, clinical practices, public health, discovery, prevention, ethics, health policy, and health law. The journal aims to serve pediatricians, researchers, health administrators, residents, and students through the prompt publication of significant advances in any field of pediatrics and to rapidly disseminate recently updated knowledge to the public. Additionally, it will initiate dynamic, international, academic discussions concerning the major topics related to pediatrics.
Manuscripts for submission to Korean J Pediatr should be prepared according to the following instructions. Korean J Pediatr follows the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, issued by the International Committee of Medical Journal Editors (ICMJE Recommendations), if otherwise not described below.

Table of Contents

Research and publication ethics

For the policies on the research and publication ethics not stated in this instructions, ‘Good Publication Practice Guidelines for Medical Journals’ (Korean Association of Medical Journal Editors), ‘Guidelines on Good Publication’ (COPE, Committee on publication ethics) and ‘Committee on Publication Ethics’ of ICMJE can be applied.

1. Author and authorship
An author is considered as an individual who has made substantive intellectual contributions to a published study and whose authorship continues to have important academic, social, and financial implications. The ICMJE has recommended the following criteria for authorship: 1) substantial contributions to conception and design, acquisition, analysis, and interpretation of data; 2) drafting the article or revising it critically for important intellectual content; and 3) final approval of the version to be published. Authors should meet criteria 1, 2, and 3. These criteria are applicable to those journals that distinguish the authors from other contributors.
2. Duplicate publication
Manuscripts are only accepted for publication in journals if they have not been published elsewhere. Manuscripts published in this journal should not be submitted for publication elsewhere. If the author(s) wishes to obtain a duplicate or secondary publication for various other reasons, such as for readers of a different language, he/she should obtain approval from the editors-in chief of both the first and second journal.
3. Conflict of interest
The corresponding author of an article is asked to inform the editor of the author’s potential conflicts of interest that may influence the interpretation of data. A potential conflict of interest should be disclosed in the manuscript even when the authors are confident that their judgments have not been influenced in preparing the manuscript. All authors should disclose their conflicts of interest, i.e., 1) financial relationships (such as employment, consultancies, stock ownership, honoraria, paid expert testimony), 2) personal relationship, 3) academic competition, and 4) intellectual passion. These conflicts of interest must be included as a footnote on the title page. Each author should certify the disclosure of any conflict of interest with his/her signature.
4. Protection of privacy, confidentiality, and written informed consent
The ICMJE has recommended the following statement for the protection of privacy, confidentiality, and written informed consent: The rights of patients should not be infringed without written informed consent. Identifying details should not be published in written descriptions, photographs, and pedigrees unless it is essential for scientific purposes and the patient (or his/her parents or guardian) provides written informed consent for publication. However, complete patient anonymity is difficult to achieve; therefore, informed consent should be obtained in the event that anonymity of the patient is not assured. For example, masking the eye region of patients in photographs is not adequate to ensure anonymity. If identifying characteristics are changed to protect anonymity, authors should provide assurance that alterations do not distort scientific meaning and editors should take note of this. When informed consent has been obtained, it should be indicated in the published article.
5. Protection of human and animal rights
While reporting experiments that involve human subjects, it should be stated that the study was performed according to the Helsinki Declaration (World Medical Association) and approved by the Research Ethics Committee (REC) or the Institutional Review Board (IRB) of the institution where the experiment was performed. The author should also include the IRB or REC institution name and number in the text. In the case of an animal study, a statement should be provided indicating that the experiment process, such as the breeding and the use of laboratory animals, was approved by the REC of the institution where the experiment was performed or that it does not violate the rules of the REC of the institution or the NIH Guide for the Care and Use of Laboratory Animals (Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council). The authors should preserve raw experimental study data for at least 1 year after the publication of the paper and should present this data if required by the editorial board.
6. Registration of the clinical research
Any research that deals with clinical trial should be registered to the primary national clinical trial registration site such as http://cris.nih.go.kr/cris/index.jsp or other sites accredited by World Health Organization or ICMJE.

Copyrights and creative commons attribution license

All published papers become the permanent property of the Korean Pediatric Society. Copyrights of all published materials are owned by the Korean Pediatric Society. They also follow the Creative Commons Attribution Non-Commercial License available from: http://creativecommons.org/licenses/by-nc/3.0/. For any commercial use of material from the open access version of the journal, permission must be obtained from the Korean Pediatric Society. Every author should sign the authorship responsibility and copyright transfer agreement form, attesting that he/she fulfills the authorship criteria. Authors are required to identify their contributions to the work described in the manuscript. The manuscript, when published, will become the property of the journal.

Manuscript submission

Authors should submit manuscripts via the electronic manuscript management system (http://submit.kjp.or.kr/) for Korean J Pediatr. Manuscripts should be submitted by the corresponding author, who should indicate the address, phone & facsimile number, and e-mail address for correspondence in the title page of the manuscript. The revised manuscript should be submitted through the same web system under the same identification numbers.

Failure to do so will result in return of the manuscript and possible delay in publication. Send all correspondence regarding submitted manuscripts to: The Korean Pediatric Society Address: Seocho World Officetel 1606, Seoun-ro 19-gil, Seocho-gu, Seoul 06732, Korea. Tel: +82-2-3473-7305, Fax: +82-2-3473-7307, E-mail: kjpped@gmail.com

1. Before the submission
We recommend that the authors use the check list provided by the journal.
[AUTHOR'S MANUSCRIPT CHECK LIST]
  • □ A covering letter stating the material has not been published previously, will not be submitted for publication elsewhere, and stating conflicts of interest of all listed authors, if any.
  • □ Have each author read the manuscript and agrees with this submission.
  • □ Copyright transform has been signed by the corresponding author.
  • □ Written permission from publishers to reproduce or adapt previously published illustrations or tables is included.
  • □ The manuscript must be written by MS Word, typing with 12-point font and double-spaced on A4 size.
  • □ Sequence of title page, abstract, and keywords, key message (recommended), graphical abstract (recommended), introduction, methods, results, discussion, acknowledgments, references, tables, figure legends, and figure in the original article.
  • □ All pages should be numbered consecutively starting with the title page.
  • □ Line numbers should insert the consecutively starting with the title page.
  • □ Title page with article title, authors full name(s), degree and affiliation, running title (less than 10 words), address for correspondence (including telephone and fax numbers and e-mail address), funding, conflict of interests, and footnotes, if any.
  • □ Abstract in structured format for original article and in unstructured format for review article (maximum of 300 words), and keywords as in MeSH.
  • □ References listed in a proper format. Check that all references listed in the references section are cited in the text and vice versa.
  • □ By reading the table title and any footnotes, the reader should be able to understand the main findings presented in the table without looking at the main text of the article.
  • □ By reading the figure legend, the reader should be able to understand the main findings presented in the figure without looking at the main text of the article.
  • □ Generic names are used for all drugs. Trade names are avoided.
2. Peer review process
Korean J Pediatr reviews all received materials. Manuscripts are sent to the two more relevant investigators, for reviews of the contents. The acceptance criteria for all papers are based on the quality and originality of the research and its clinical and scientific significance. An initial decision will normally be made within 2 weeks after the agreement of review by the reviewers, and the reviewers’ comments will then be sent to the corresponding authors. Revised manuscripts must be submitted online by the corresponding author. Failure to resubmit the revised manuscript within due date of the editorial decision is regarded as a withdrawal. The editorial office should be notified if additional time is needed or if an author chooses not to submit a revision. The editorial committee makes decisions concerning editing, revision, and acceptance or rejection, and editing may include shortening an article, reducing the number of illustrations or tables, or changing the paper's format or the order of the manuscript. The editor selects referees results of the review will be classified as follows:
  • Accepted: The manuscript will be forwarded to the publisher without further corrections.
  • Minor revisions: The author should address the comments from the reviewers, which will be confirmed by the reviewers.
  • Major revisions: The author should address the comments from the reviewers and make the appropriate corrections for review by the three reviewers.
  • Rejection: When one out of the three reviewers rejects the manuscript, the final decision is made by the editorial committee.
  • Consultation: Review of the manuscript will be done through consultation to subcommittees and subspecialties.
3. Conditions of publication
All authors are required to affirm the following statements prior to their manuscript being considered:
  • 1) If the manuscript doesn't have a new result or conclusion, then it shouldn't have the same title as a previously published review article.
  • 2) Once the case has been published in an original paper, it may not be reproduced as a case report. However, only in circumstances in which a novel diagnostic method, a novel therapeutic trial, or a previously unknown accompanying condition is found will the editorial board determine the possibility of acceptance.
  • 3) Clinical trials on drugs with commercial implications will be reviewed by the proper subcommittee or subspecialty before being reviewed for publication.
  • 4) The editorial board will make an exception only if the clinical picture supply a unique, educational, practical information to the reader of Korean J Pediatr.
  • 5) Rejected manuscripts may not be resubmitted.
  • 6) If the author does not address the comments made by the reviewer or if the manuscript does not follow the guidelines provided, it will be rejected.
4. Manuscripts after acceptance
1) Final version upload
When accepted for publication, the authors’ institutional affiliations should be inserted into the text of the final revised manuscript and uploaded to the online submission system. Files containing figures must be named according to the figure number (ex: Fig1.jpg).
2) Galley proof
After corrections have been made, an accepted manuscript will be sent to the publisher for printing. The proof may be revised more than once by the corresponding author, if needed. The author should double-check for corrections in the content, title, affiliation, capitalization, locations of figures, and references. Corresponding authors are responsible for further corrections made after printing.
3) Confirmation of acceptance
Once the manuscript is at the publisher, confirmation of acceptance by the Korean J Pediatr may be issued. Registering for the board exams, a receipt of confirmation with two reprints may be ordered for the accepted.
5. Rapid publication
A researcher who wishes to publish quickly should contact the editorial office first. Rapid publication means the manuscript will undergo a rapid peer-review process within two weeks of receipt and publication in the next issue, if accepted. Researchers who wish to publish quickly should first submit a $100 fee to Korean Journal of Pediatrics. This fee ensures rapid review but does not guarantee acceptance for publication. If the peer reviewer approves the publication within the two-week period, the author should submit $400 to the Korean J Pediatr office for publication in the next issue.
6. Reprint
Reprints are available at any time after publication; however, reprints ordered after publication may be subject to increases in price. A page charge will be requested from the corresponding author, and color photographs will require an additional fee.

Manuscript preparation

1. Publication type
Korean J Pediatr publishes perspectives, review articles, editorials, original articles, letter to the editors, clinical note, correspondence and replies.
Perspectives
Perspectives may address important pediatric topics such as research, education, training, clinical practices, public health, discovery, prevention, ethics, health policy, or health law, and they are generally not linked to a specific article. For questions or suggestions about a Perspectives submission, please contact kjpped@gmail.com.
Reviews, Guidelines, and Position Papers
Reviews include articles covering systematic- and/or metaanalyses, review articles, guidelines, and position papers. Review articles use informal methods to collect and interpret information, which is often summarized subjectively in a narrative form. Narrative reviews are especially suitable for describing cutting-edge and evolving developments and underlying theory. Systematic- and/or Meta-analyses systematically find, select, critique, and synthesize evidence relevant to well-defined questions about diagnosis, prognosis, or therapy. The Guidelines format is an official recommendation from professional organizations on issues related to clinical practice and healthcare delivery. Position Papers are official statements from professional organizations on issues related to clinical practice, healthcare delivery, and public health.
Review articles should have following structures:
Title page, Unstructured abstract and Keywords, Key message (recommended), Graphic abstracts (recommended), Main text (Introduction, Body text, Conclusion), Acknowledgments (if necessary), References, Tables, Figure legends and Figures.
Editorials
An editorial is a commentary on current topics or on papers published elsewhere in the issue. Editorials are invited by the Editor.
Original articles
Original articles are papers containing the results of clinical or laboratory investigations, which are sufficiently well documented to be acceptable to critical readers.
The manuscript for original articles should be organized in the following order:
Title page, Structured abstract and Keywords, Key message (recommended), Graphic abstracts (recommended), Introduction, Methods, Results, Discussion, Acknowledgments (if necessary), References, Tables, Figures Legends and Figure.
Letter to the Editors
A Letter to the Editors is a concise, focused preliminary report, but may represent original observations. It is subject to peer review. It should begin with the salutation “To the Editor.” There should not be a separate abstract, but rather a concluding paragraph that sums up the Letter. Authors’ names, affiliations, funding sources, and conflicts of interests should be listed at the end following references.
Clinical Note
Korean J Pediatr now welcomes the submission of an image or video for a newly added feature in the online and print versions of the journal. A Clinical Note is a short report on a unique, educational, or practical image or video of the pediatric area. In addition to seeking images of clinical data, we are also looking for other interesting types of images or video, including radiographs, pathology, CT scans, MRIs, lab tests, or other testing procedures. The text should include a brief patient history and laboratory findings, and it should put the high-quality image or video clip in context, explaining what the image shows, why it is of interest to the pediatrician, and the outcome of the patient. Authors must obtain signed informed consent for publication in print. Do not use “blackout” bars or similar devices to anonymize patients; if you have received consent appropriately, masking is not necessary. Please also write a short question of approximately 20 words with four short answers to create an accompanying quiz for readers to choose a single best answer. These questions should be appropriate for a general pediatrician. Authors’ names, affiliations, funding sources, and conflicts of interests should be listed at the end following references.
Correspondence and replies
We welcome correspondence on content published in Korean J Pediatr. Correspondence concerning recent publications in the Journal will be considered for publication. Correspondence is not usually peer reviewed but accepted on the basis of pertinence and scientific quality. The journal may invite replies from the authors of the original publication or pass on the correspondence to these authors. All accepted correspondence is edited, and proofs will be sent out to authors before publication. Upon review and approval by the Editor, the correspondence and relevant replies will be published together.
Summary of article type
*Main Text word count exclude abstract, reference, table and figure legends.
*Figure included the video.
2. Reporting guidelines for specific study designs
For the specific study design, such as randomized control studies, studies of diagnostic accuracy, meta-analyses, observational studies, and non-randomized studies, it is recommended that the authors follow the reporting guidelines listed in the following table.

Format of manuscript

1. Title page
This should contain the title of the article, full names of authors, degree, and institutional affiliation(s). If several authors and institutions are listed, it should be made clear with which department and institution each author is affiliated. For a multicenter study, indicate each individual’s affiliation using a superscript Arabic number 1,2,3.... In a separate paragraph, an address for correspondence including the name of the corresponding author and his/her degree, address (institutional affiliation, city, zip code and country), telephone and facsimile numbers, and e-mail address should be given. The running title, of 10 words or less, should not be a declarative or interrogative sentence. Funding and conflicts of interest must be included as a footnote on the title page.
2. Abstract and keywords
The abstract in original article should be concise (less than 300 words) and describe concisely the Background, Purpose, Methods, Results, and Conclusion, in a structured format. Abbreviations, if needed, should be kept to an absolute minimum, and given with proper identifications.
Abstracts for review articles (systemic & meta-analysis, review article, guidelines and position paper) provide within one paragraph the background, purpose, methods, important results, and derived conclusion of the study in an unstructured format, but carry the same word count restrictions.
Below the abstract, authors should provide, and identify as such, up to 5 keywords or short phrases that will assist indexers in cross-indexing the article and can be published with the abstract. Use terms from the medical subject headings (MeSH) list of Index Medicus; if suitable MeSH terms are not yet available for recently introduced terms, present terms may be used. The first letter of a keyword should be capitalized (e.g., Metabolic disease, Asthma).
3. Key message
Korean J Pediatr recommends submission of a Key Message in the original article of the journal. The Key Message will be accompanied by a highlights box that provides answers (no longer than 70 words) to the following:
Question;
Finding;
Meaning;
4. Graphical abstracts
Although a graphical abstract is optional, its use is encouraged as it draws more attention to the article. The graphical abstract should summarize the contents of the article in a concise, pictorial form designed to capture the attention of a wide readership. Graphical abstracts should be submitted as a separate file in the online submission system. Image size: Please provide an image with a minimum of 531×1328 pixels (h×w) or proportionally larger. The image should be readable at a size of 5×13 cm using a regular screen resolution of 96 dpi. Preferred file types: TIFF, EPS, PDF, or MS Office files.
5. Main text
The manuscript should be written in clear and concise English. Authors whose primary language is not English should obtain assistance with writing to avoid grammatical problems. The text should be organized in sections as follows: Introduction, Methods, Results, and Discussion. Each section should begin on a new page.
1) Introduction
General enough references to the most pertinent papers, to inform readers; and others relevant findings are described here. It also includes the specific question driving the authors particular investigation.
2) Methods
We endorse the principles embodied in the Declaration of Helsinki and expect that all investigations involving human materials have been performed in accordance with these principles. In studies involving human subjects, a statement describing approval by the appropriate Institutional Review Board is required. Studies involving experimentation with animals must include a statement indicating which guidelines were followed for the care and use of the animals. An explanation of the experimental methods should be concise and sufficient for repetition by other qualified investigators. Procedures that have been published previously should not be described in detail; however, new or significant modifications of previously published procedures need full descriptions. The sources of special chemicals or preparations should be given (i.e., name of company, city and state, and country). Methods of statistical analyses and criteria of significance level should be described.
Clearly describe the selection of observational or experimental participants (healthy individuals or patients, including controls), including eligibility and exclusion criteria and a description of the source population. Because the relevance of such variables as age, sex, or ethnicity is not always known at the time of study design, researchers should aim for inclusion of representative populations into all study types and at a minimum provide descriptive data for these and other relevant demographic variables. Ensure correct use of the terms sex (when reporting biological factors) and gender (identity, psychosocial or cultural factors), and unless inappropriate, report the sex and/or gender of study participants, the sex of animals or cells, and describe the methods used to determine sex and gender. If the study was done involving an exclusive population, for example in only one sex, authors should justify why, except in obvious cases (e.g., prostate cancer). Authors should define how they determined race or ethnicity and justify their relevance.
3) Results
This part should be presented logically using text, tables, and illustrations. Excessive textual repetition of table or figure contents should be avoided.
4) Discussion
The data should be interpreted concisely without repeating materials already presented in the Results section. Speculation is permitted, but it must be supported by the authors presented data and be well-founded.
6. Acknowledgments
All persons who have made substantial contributions, but who are not eligible as authors, are named in the acknowledgments section. Information concerning sources of financial support should be given in this section.
7. References
It is the Editors' expectation that authors will perform a comprehensive search of the literature to gather the most current articles relevant to the subject matter. All references that are five years old or more should be replaced with current literature, unless the referenced publication is a classic work that underscores the core subject.
References should be numbered consecutively in the order in which they are first mentioned in the main text. Each reference should be cited as superscript Arabic number 1), 1, 2), or 1-3), at the end of the related sentence in the text. Reference citations in the main text should be made with consecutive numbers in parenthesis (Vancouver style). In the Reference section, they should be listed in the order of citation within the main text, together with the corresponding number.
  • • Authors are responsible for the accuracy and completeness of their references and correct text citations.
  • • Papers in press may be listed among the references with the journal name and tentative year of publication.
  • • Unpublished data or personal communications can be listed only with the author's written permission.
  • • Other types of references not described below should follow The NLM Style Guide for Authors, Editors, and Publishers (http://www.nlm.nih.gov/citingmedicine).
Examples of reference style
Journal article
  • 1. Lee JY, Lee BH, Kim GH, Jung CW, Lee J, Choi JH, et al. Clinical and genetic characteristics of Gaucher disease according to phenotypic subgroups. Korean J Pediatr 2012;55:48-53.
Book & Book chapter
  • 2. Volpe JJ. Neurology of the newborn. 5th ed. Philadelphia: Saunders/Elsevier, 2008.
  • 3. Hong CE. Textbook of pediatrics. 9th ed. Seoul: Korea Textbook Publishing Co., 2008.
  • 4. Pan ES, Cole FS, Weinttrub PS. Viral infections of the fetus and newborn. In: Taeusch HW, Ballard RA, Gleason CA, editors. Avery’s diseases of the newborn. 8th ed. Philadelphia: Elsevier Saunders, 2005:495-529.
Website
  • 5. International Committee of Medical Journal Editor. Uniform requirements for manuscripts submitted to biomedical journals: writing and editing for biomedical publication [Internet]. Philadelphia: International Committee of Medical Journal Editor; c2009 [cited 2012 Nov 1]. Available from: http://www.icmje.org/urm_main.html.
8. Table
Tables should be typed double-spaced on separate pages within manuscript, and they should be titled and numbered in Arabic numerals in the order of their first citation in the text. Each column should be given a short heading. Only the first letter of the first word in each row and column should be capital letters. If numerical measurements are given, the unit of measurement should be included in the each heading. The statistical significance of observed differences in the data should be indicated by the appropriate statistical analysis. All abbreviations should be defined in footnotes. For special remarks, superscripts *, †, ‡, §, ∥, ¶, **, ††, ‡‡... should be used.
9. Figure legend
The legend and figure form a separate unit and must be fully self-explanatory. By reading the legend, the reader should be able to understand the main findings in a figure without looking at the text of the article. Additional figures may be submitted as supplementary information, subject to peer review, for publication in the Online Data Supplement. Figure legend for each light microscopic photograph should include name of stain and magnification (i.e., H&E, ×400); electron microscopic photography should have an internal scale marker. All the legends for figures should be double-spaced. Do not use a separate sheet for each legend.
10. Figure and Video
1) Figure
We recommended color on all images in the manuscript. All of them must have a minimum resolution of 300 dpi, width 107 mm. The figures should be numbered in the form Fig. 1, Fig. 2, and Fig. 3. Related figures should be combined into one figure, with each subfigure denoted by the letters, A, B, C, and so on, following the Arabic number of the main figure (i.e., Fig. 1A; Fig. 1B, C; Fig. 1A-C). Figures should be submitted as Tiff or EPS file format. If the only possible file format is JPEG, it must be in highest quality with minimum compression.
Color for online images is free, but the entire expense of reproducing color photographs for offline print images will be charged to the author. Current estimates for color reproduction can be obtained from the Editorial Office.
2) Video
The paper to which the video clip relates should be mentioned in the recording. Video files should be accompanied by a brief text explaining the content of the video, title of the video, date of recording, and place of recording, if relevant. Written consent from all parties must be supplied at submission.
Video material should be submitted in .mp4 format with an aspect ratio of 16:9 and be no larger than 50 Mb. We welcome your videos and invite you to submit any video material (reports, interviews, scans, imaging) for consideration in the online journal. Please ensure that anyone featured in the video has given permission for publication (see also the previous section on patient and other consents). All video files can be submitted alongside your article.
  • SCImago Journal & Country Rank


ABOUT
TOPICS

Browse all articles >

ARTICLE CATEGORY

Browse all articles >

BROWSE ARTICLES
AUTHOR INFORMATION
Editorial Office
#1606 Seocho World Officetel, 19 Seoun-ro, Seocho-ku, Seoul 06732, Korea
Tel: +82-2-3473-7305    Fax: +82-2-3473-7307    E-mail: kjpped@gmail.com                

Copyright © 2019 by Korean Pediatric Society. All rights reserved.

Developed in M2community

Close layer
prev next